Cited 0 times in Scipus Cited Count

Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis.

DC Field Value Language
dc.contributor.authorKim, JY-
dc.contributor.authorPark, JS-
dc.contributor.authorPark, JC-
dc.contributor.authorKim, ME-
dc.contributor.authorNahm, DH-
dc.date.accessioned2014-05-22T05:53:48Z-
dc.date.available2014-05-22T05:53:48Z-
dc.date.issued2013-
dc.identifier.issn1744-9979-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/10078-
dc.description.abstractThe management of recalcitrant atopic dermatitis (AD) is a challenging issue for both clinicians and patients. In this study, we evaluate the clinical efficacy and safety of double-filtration plasmapheresis (DFPP) in patients with recalcitrant AD. Eighteen patients with recalcitrant AD whose clinical condition had not been effectively controlled by current standard medical therapies were treated by either a single course of DFPP (N = 9) or with standard medical therapies only (N = 9). Clinical severity of AD was measured at baseline and at 1 and 4 weeks after treatment in patients in the DFPP group and at the corresponding time points in the control group using the standardized clinical severity scoring system for atopic dermatitis (SCORAD). In the nine patients who underwent DFPP, SCORAD values significantly decreased from 80.6 ± 16.7 (mean ± SD) at baseline to 65.9 ± 20.1 at 1 week and 69.8 ± 20.4 at 4 weeks after DFPP treatment (Wilcoxon signed-rank test, P < 0.05). No significant side-effects were observed during DFPP treatment. In the nine patients with recalcitrant AD who were treated with standard medical therapies, there were no significant differences between the SCORAD values at baseline (70.6 ± 13.9), 1 week (68.0 ± 14.4), and 4 weeks (69.8 ± 17.7) (P > 0.05). DFPP resulted in significant clinical improvements in patients with recalcitrant AD. Further studies are needed to evaluate the long-term clinical usefulness of DFPP in the treatment of patients with recalcitrant AD.-
dc.language.isoen-
dc.titleDouble-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis.-
dc.typeArticle-
dc.identifier.pmid24330559-
dc.contributor.affiliatedAuthor박, 준성-
dc.contributor.affiliatedAuthor남, 동호-
dc.type.localJournal Papers-
dc.identifier.doi10.1111/1744-9987.12047-
dc.citation.titleTherapeutic apheresis and dialysis-
dc.citation.volume17-
dc.citation.number6-
dc.citation.date2013-
dc.citation.startPage631-
dc.citation.endPage637-
dc.identifier.bibliographicCitationTherapeutic apheresis and dialysis, 17(6). : 631-637, 2013-
dc.identifier.eissn1744-9987-
dc.relation.journalidJ017449979-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse